ArticleScientific reports2025
A machine learning model for predicting 28-day mortality in ICU patients with community-acquired pneumonia and acute kidney injury.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury is a common and critical complication in patients with community-acquired pneumonia who are admitted to intensive care units, substantially increasing their risk of short-term mortality. To enhance early clinical decision-making, we developed and validated multiple machine learning-based survival models to predict 28-day mortality using data from the Medical Information Mart for Intensive Care (MIMIC IV and MIMIC III databases). Five models were evaluated: Random Survival Forests, Gradient Boosting Machine, Lasso-Cox, CoxBoost, and Survival-SVM. Among these, the CoxBoost model demonstrated superior predictive performance with an AUC of 0.737in internal validation cohort and an AUC of 0.671 in external validation cohort, outperforming established clinical scoring systems. Decision curve analysis indicated high net benefit across a clinically relevant range of predicted risks. Key predictive features identified by model interpretation included age, vasopressor use, NSAIDs use, hemoglobin level, hypertension, and blood urea nitrogen. To improve practical application, we developed a web application that allows for individualized, real-time mortality risk prediction at the bedside. This tool may help identify high-risk patients earlier and support timely, personalized treatment strategies in critical care environments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.